As of 3:29pm ET
| -0.20 / -1.26%|
The 7 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 18.90, with a high estimate of 59.74 and a low estimate of 11.57. The median estimate represents a +20.91% increase from the last price of 15.63.
The current consensus among 8 polled investment analysts is to Buy stock in Mesoblast Ltd. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.